Weight Management & Adiposity Research
Peptides investigated in appetite regulation, energy intake and adiposity research, primarily through incretin receptor agonism.
GLP-1 / GIP receptor agonism & energy balance
GLP-1 and GIP receptor agonism, appetite signaling, energy-intake regulation, adiposity and weight-management research models.
Scientific Background
Weight-management research peptides act principally through incretin receptor agonism (GLP-1, GIP and glucagon pathways) and are studied for effects on appetite regulation, energy intake and adiposity in preclinical and clinical research models.
8 products in this category
NEWWeight Management99.2%Peptide Sciences Semaglutide
GLP-1 receptor agonist studied in appetite regulation, glucose-dependent insulin secretion and adiposity research.
NEWWeight Management99.3%Peptide Sciences Tirzepatide
Dual GIP and GLP-1 receptor agonist studied in adiposity, appetite regulation and energy-balance research.
NEWWeight Management99.0%Peptide Sciences Retatrutide
Triple GIP, GLP-1 and glucagon receptor agonist studied in adiposity and energy-expenditure research.
NEWWeight Management99.1%Peptide Sciences Cagrlintide
Amylin and calcitonin receptor agonist studied in appetite suppression and adiposity research.
NEWWeight Management99.2%Peptide Sciences Liraglutide
Long-acting GLP-1 receptor agonist studied in appetite regulation and adiposity research.
NEWWeight Management≥98%Semaglutide
GLP-1 receptor agonist studied in appetite regulation, energy intake and adiposity research.
NEWWeight Management≥98%Tirzepatide
Dual GIP/GLP-1 receptor agonist studied in appetite regulation and adiposity research.
NEWWeight Management≥98%Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist studied in adiposity and energy-balance research.